A phase Ib study of pembrolizumab (MK-3475) in patients with advanced triple-negative breast cancer

The requested reference [13cb904dc562a5dfb008e961f85b96bfe9ae805a] no longer exists in our database. It has been replaced by the current reference: [c67c4d86e023960b324671a7c74a9a936bb57ef4]

Authors
Category Primary study
JournalCancer Research
Year 2015
This article has no abstract
Epistemonikos ID: 7d9125bbc47958304a62cfac9ba0243c3d0b3d9b
First added on: Feb 07, 2025